A novel alkaloid scaffold was designed through scaffold-hopping strategy based on the active pyrazines alkaloid isolated previously. A total of 25 derivatives were synthesized based on this scaffold and evaluated for their antitumor activities. Among all these tested compounds, 9f exhibited most excellent antitumor activities toward H460 cells, TMD-8 cells, and MV4-11 cells in vitro by 3-(4, 5dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay with IC 50 values of 29.8, 14.9, and 18.8 μM, respectively.
Cancer is one of most serious public health problems representing the leading cause of morbidity and mortality worldwide, which causes great social and economic burdens. 1 Natural products have been considered as important sources for drug discovery, which could be developed for the treatment of various diseases. "Fu zi," also named Radix Aconiti Lateralis Praeparata, is the lateral root of Aconitum carmichaelii, which is widely distributed in Sichuan Province of China and is often used as agents toward various diseases. [2] [3] [4] Our previous study on "Fu zi" resulted in the isolation of 7 nonditerpene alkaloids, among which 2 new pyrazines (Figure 1, compounds 1 and 2) showed moderate antitumor activity. 5 Given this result, 2 lead compounds are considered as potentially novel scaffold or pharmacophore with antitumor activity. In the present study, the scaffold-hopping strategy was utilized to design new scaffold based on the lead compounds. 6 A water-soluble group, secondary amine moiety, was introduced as a linkage between hydrophobic head and hydrophilic tail ( Figure 1 ). Then, we modified the hydrophobic head with various aromatic rings to identify new compounds with better antitumor activity. Also, compounds with contrary configuration of lead compounds were synthesized and evaluated for their antitumor activities to ascertain the structure-activity relationships that determine the antitumor activities of the synthesized compounds.
The starting materials were (S)-3-aminopropane-1,2-diol (4) and various aromatic aldehydes (3a-3p). Scheme 1 shows that (S)-3-aminopropane-1,2-diol (4) was treated with different aromatic aldehydes (3a-3p) in dry Dichloromethane (DCM) to achieve the aromatic imines (5) . Once the completion of the transformation monitored by thin-layer chromatography (TLC), reducing agents, including NaBH 4 , STAB, and NaBH 3 CN, were added to the reaction mixture. [7] [8] [9] The reactions were allowed to stir at room temperature to give the final products. However, only reaction treated with NaBH 4 performed good conversion. The reduced target compounds 6a to 6p were isolated using column chromatography over silica gel with elution by DCM and DCM-MeOH with a gradually increasing volume of MeOH.
Derivatives 9a to 9i were synthesized similar to derivatives 6a to 6p, which were depicted in scheme 2.
All these target compounds were evaluated for their antiproliferative activities against tumor cell lines, including H460 cells (human nonsmall-cell lung cancer cells), TMD-8 cells (human diffuse large B-cell lymphoma cells), and MV4-11 cells (biphenotypic B myelomonocytic leukemia cells), in vitro by 3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetraz olium bromide (MTT) assay. Each experiment was repeated 3 times. The results of these studies are summarized in Table 1 .
As illustrated in Table 1 , the Sconfiguration compound 6g, in which the 3,5-di-tertbutyl-2-hydroxyl phenyl was introduced as the hydrophobic head, exhibited good antitumor activities against 2 tested tumor cell lines, including H460 and MV4-11 cells, with IC 50 values of 40.8 and 34.3 µM, respectively. The Sconfiguration compound 6i with a 5-(4-nitrophenyl)furan-2-yl moiety as hydrophobic head showed good activities against all tested cell lines, with IC 50 values of 53.8, 62.6, and 43.5 µM, respectively. In addition, compound 6g showed weak activity against TMD-8 (IC 50 = 65.6 µM), whereas compound 6i moderately inhibited its growth (IC 50 = 62.6 µM). The Rconfiguration compound 9h, featuring same hydrophobic head of compound 6g, presented same level of antitumor activities of 6g against all 3 tumor cell lines, with IC 50 values of 40.8, 65.6, and 34.3 µM, respectively. Notably, among all compounds, 9f with the same hydrophobic head of compound 6i exhibited most excellent activities against tested tumor cell lines, with IC 50 values of 29.8, 14.9, and 18.8 µM, respectively. The aforementioned results demonstrated that Rconfiguration analogs were more potent than the Sconfiguration analogs from the lead compounds. 
29. 8 0.044 ± 0.013 0.049 ± 0.020 0.033 ± 0.009 a The data are expressed as the mean ± SD. All experiments were independently performed at least 3 times. b Used as a positive control.
In conclusion, 25 new pyrazines alkaloid derivatives were successfully synthesized and evaluated cytotoxic activity against 3 cancer cell lines. The results indicate that some of these derivatives possess at least moderate cytotoxic activity. Among all these tested compounds, 9f exhibited most excellent antitumor activities, which implied that continued searching for new antitumor agents based on the aforementioned scaffold is promising.
Experimental

General
The reactions were monitored by TLC with silica gel GF254 plates, which were visualized by ultraviolet (UV) light (254 nm). 1 H Nuclear Magnetic Resonance (NMR) spectra were measured on a Bruker 600 and 400 MHz spectrometer at 25°C, and referenced to Me 4 Si. Chemical shifts are reported in ppm (δ) using the residual solvent line as an internal standard. Splitting patterns are designed as s, singlet; d, doublet; t, triplet; m, multiplet. NMR spectra were taken in Dimethylsulfoxide (DMSO) with Tetramethylsilane (TMS) internal standard on a Bruker SF-400 spectrometer (operating frequency 400 MHz). Starting materials and solvents were purchased from common commercial suppliers and were used without further purification.
General Procedure for Preparation of Conjugates Between Triterpenoid and 1,2-Diaminobenzene 6a-6p and 9a-9i
. (S)-3-Amino-1,2-propanediol (1.0 g, 11 mmol) was dissolved in chloroform (30 mL) and methanol (10 mL), and 3,4-dimethylbenzaldehyde (1.33 mL, 10 mmol) was added to the solvent and stirred for 1 hour at room temperature. Sodium borohydride (378.4 mg, 10 mmol) was added and the mixture was stirred for 12 hours at room temperature. After the reaction was complete, the solution was removed under reduced pressure and the residue was purified with column chromatography (DCM/CH 3 
(S)-3-((3,5-Di-tert-butyl-2-hydroxybenzyl)amino)propane-1,2-diol (6g
(S)-3-((Pyridin-4-ylmethyl)amino)propane-1,2-diol (6h
(S)-3-(((1-Methyl-5-nitro-1H-imidazol-2-yl)methyl)amino)propane-1,2diol (6j
